It takes all of us to cure each of us SM
The Harvard Business School Kraft Precision Medicine Accelerator will call on energetic leaders across disciplines to do what they do best: To question everything. To speed innovation and medical breakthroughs across disease states to market. And to share those new models and best practices, encouraging rapid adoption throughout the community.
A carefully conceived process developed for the utmost speed
The Accelerator seeks to create a virtuous cycle of turning ideas into action.The Accelerator will speed the adoption of precision medicine by prioritizing the challenges that exist today, equipping and supporting leaders to develop actionable solutions, and disseminating best practices to promote efficiency and speed.
First we gather. Next, we solve.
Data Sharing & Analytics Kickoff, June 2016
The Accelerator's first leadership forum, Advancing Precision Medicine Models: Integrating Science, Technology & Business, focused on the challenges and solutions of data generation, aggregation, sharing, and analytics.
The Kraft Precision Medicine Accelerator was made possible by a generous gift of $20 million from The Kraft Family Foundation, under the leadership of Foundation President Robert K. Kraft (MBA 1965) and Jonathan Kraft (MBA 1990). Harvard Business School will collaborate with the Broad Institute and other leading organizations to accelerate breakthroughs in precision medicine.
→ Kathy Giusti Joins HBS to Co-Chair the Kraft Precision Medicine Accelerator
Kathy Giusti, Faculty Co-Chair, Founder, Multiple Myeloma Research Foundation
Richard Hamermesh, Faculty Co-Chair, Harvard Business School
Jonathan Kraft, President, The Kraft Group
Robert Kraft, Founder, Chairman & CEO, The Kraft Group
Nitin Nohria, Dean, Harvard Business School